- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07941037
Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand
Effect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the Hand: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
This clinical trial will investigate whether non-compressive therapeutic gloves improve hand function and reduce pain in people with hand osteoarthritis. The gloves contain semiconductor elements embedded in their fabric. Researchers will compare these gloves with visually identical placebo gloves that do not contain semiconductor elements.
The main question is whether the active gloves improve hand function after 12 weeks compared with placebo gloves. Researchers will also assess pain, grip strength, symptoms and changes seen on magnetic resonance imaging (MRI) over nine months.
The study will involve at least 154 participants aged 39 years or older with diagnosed hand osteoarthritis who do not require immediate hand surgery. It will take place at MSK House in Sleaford, United Kingdom.
After providing written informed consent, participants will be assigned by chance to one of two groups. Each participant will have an equal chance of receiving active or placebo gloves. Neither participants nor the clinical team will know which gloves have been assigned.
Participants will:
- Wear the assigned glove or gloves on their affected hand or hands for at least 20 hours each day, including overnight, during the first 12 weeks.
- Continue wearing the gloves for at least 12 hours each day, including overnight, for the remainder of the nine-month study.
- Complete questionnaires about hand pain and function before treatment and at three, six and nine months.
- Attend the study site at the beginning and at nine months for assessments, including grip strength testing and MRI scans of the hand and wrist.
- Record their hand pain, glove use and pain medication use in a weekly diary.
Participants may also complete a short video-based movement assessment at the first and last study visits.
The main measure of hand function will be the Australian Canadian Osteoarthritis Hand Index (AUSCAN), a questionnaire about hand symptoms and difficulty with everyday activities. Other assessments will measure pain, hand function, grip strength and changes in the hand joints.
The research team will record unwanted effects during the study. Participants who experience discomfort, irritation or a skin reaction will be advised to remove the gloves and contact the study team.
The findings will help determine whether these therapeutic gloves have a role in managing hand osteoarthritis.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Paul Lee
- Numero di telefono: +44 330 001 0048
- Email: research@mskdoctors.com
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Diagnosed erosive hand osteoarthritis, non-erosive hand osteoarthritis or first carpometacarpal joint osteoarthritis.
- Mild, moderate or severe hand osteoarthritis on MRI assessment, without an indication for immediate surgery.
- Hand pain attributable to diagnosed hand osteoarthritis within the previous six months.
- Aged 39 years or older.
- Willing and able to comply with the follow-up schedule and study requirements.
- Willing and able to provide written informed consent.
Exclusion Criteria:
- Known history of neurological conditions, including multiple sclerosis or Parkinson's disease.
- Surgical treatment of the hands within the previous five years or injection treatment of the hands within the previous six months.
- An indication for immediate surgery to treat hand osteoarthritis.
- Secondary causes of arthritis, including gout, rheumatoid arthritis or psoriatic arthritis.
- Use of topical creams or gels for arthritic pain within the previous week, including non-steroidal anti-inflammatory drugs, capsaicin, lidocaine or counterirritants.
- History of carpal tunnel syndrome, cubital tunnel syndrome or radial tunnel syndrome.
- History of peripheral neuropathy.
- Chronic pain conditions unrelated to the hand condition.
- Known autoimmune disease other than arthritis.
- Tobacco use within the previous 90 days.
- Aged under 39 years.
- Active local or systemic infection.
- Unwilling or unable to provide written informed consent.
- Any other condition or circumstance that, in the investigator's opinion, would prevent completion of the study or confound the study results.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Icrediwear Group
Participants receive active semiconductor-embedded gloves to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment. |
Non-compressive therapeutic gloves with semiconductor elements incorporated into the fabric. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use. |
|
Comparatore placebo: Placebo Group
Participants receive identical gloves without semiconductor elements to wear on their affected hand or hands for nine months. Gloves are worn for a minimum of 20 hours per day, including overnight, during the first 12 weeks, followed by at least 12 hours per day, including overnight, until the nine-month assessment. |
Visually identical non-compressive gloves without semiconductor elements. The gloves cover the hand and fingers, with open fingertips. The research team selects the appropriate size, fits the gloves and provides instructions for use. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in Hand Function Assessed Using the Australian Canadian Osteoarthritis Hand Index (AUSCAN)
Lasso di tempo: Baseline and 12 weeks
|
Baseline and 12 weeks
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Change in Hand Pain Assessed Using a Visual Analogue Scale
Lasso di tempo: Baseline and months 3, 6 and 9.
|
Baseline and months 3, 6 and 9.
|
|
Change in Functional Index for Hand Osteoarthritis (FIHOA) Score
Lasso di tempo: Baseline and months 3, 6 and 9.
|
Baseline and months 3, 6 and 9.
|
|
Change in Grip Strength
Lasso di tempo: Baseline and month 9.
|
Baseline and month 9.
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 2024-24
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .